302 Military Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhao, Ping
KEYNOTE-585 China Extension study, NCT04882241: Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension

Active, not recruiting
3
120
RoW
Pembrolizumab, MK-3475, KEYTRUDA®, Placebo, Normal saline solution, Cisplatin, PLATINOL®, Capecitabine, XELODA®, 5-fluorouracil, ADRUCIL®, 5FU, Docetaxel, TAXOTERE®, Oxaliplatin, ELOXATIN®, Leucovorin, WELLCOVORIN®
Merck Sharp & Dohme LLC
Gastric Cancer, Gastroesophageal Junction Cancer
02/24
04/25
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Active, not recruiting
3
878
RoW
JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy
Shanghai Junshi Bioscience Co., Ltd.
Gastric or Esophagogastric Junction Adenocarcinoma
06/26
07/28
DRAGON - IV, NCT04208347: Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Active, not recruiting
2/3
580
RoW
Apatinib 250mg, Camrelizumab, S-1, Oxaliplatin, Apatinib 500mg
Ruijin Hospital
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
12/24
08/25
NCT06155383: Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

Recruiting
2
90
RoW
Capecitabine, oxaliplatin, Disitamab Vedotin, RC48, Toripalimab, JS001
RemeGen Co., Ltd.
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
01/25
12/27
NCT05226819: Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

Recruiting
N/A
300
RoW
PPI quadruple therapy
Second Affiliated Hospital of Xi'an Jiaotong University
Helicobacter Pylori Infection
09/22
03/23
NCT05455372: Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy

Recruiting
N/A
600
RoW
PPI quadruple therapy
Second Affiliated Hospital of Xi'an Jiaotong University
Helicobacter Pylori Infection
09/23
03/24
NCT05673499: International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery

Recruiting
N/A
900
Europe, US, RoW
NIRS/EEG monitoring
Children's Hospital of Philadelphia, Masimo Corporation
Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
12/24
12/25
Li, Baosen
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhao, Ping
KEYNOTE-585 China Extension study, NCT04882241: Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension

Active, not recruiting
3
120
RoW
Pembrolizumab, MK-3475, KEYTRUDA®, Placebo, Normal saline solution, Cisplatin, PLATINOL®, Capecitabine, XELODA®, 5-fluorouracil, ADRUCIL®, 5FU, Docetaxel, TAXOTERE®, Oxaliplatin, ELOXATIN®, Leucovorin, WELLCOVORIN®
Merck Sharp & Dohme LLC
Gastric Cancer, Gastroesophageal Junction Cancer
02/24
04/25
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Active, not recruiting
3
878
RoW
JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy
Shanghai Junshi Bioscience Co., Ltd.
Gastric or Esophagogastric Junction Adenocarcinoma
06/26
07/28
DRAGON - IV, NCT04208347: Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Active, not recruiting
2/3
580
RoW
Apatinib 250mg, Camrelizumab, S-1, Oxaliplatin, Apatinib 500mg
Ruijin Hospital
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
12/24
08/25
NCT06155383: Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

Recruiting
2
90
RoW
Capecitabine, oxaliplatin, Disitamab Vedotin, RC48, Toripalimab, JS001
RemeGen Co., Ltd.
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
01/25
12/27
NCT05226819: Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

Recruiting
N/A
300
RoW
PPI quadruple therapy
Second Affiliated Hospital of Xi'an Jiaotong University
Helicobacter Pylori Infection
09/22
03/23
NCT05455372: Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy

Recruiting
N/A
600
RoW
PPI quadruple therapy
Second Affiliated Hospital of Xi'an Jiaotong University
Helicobacter Pylori Infection
09/23
03/24
NCT05673499: International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery

Recruiting
N/A
900
Europe, US, RoW
NIRS/EEG monitoring
Children's Hospital of Philadelphia, Masimo Corporation
Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
12/24
12/25
Li, Baosen
No trials found

Download Options